123 related articles for article (PubMed ID: 26870298)
1. Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage.
Garnier A; Ilmer M; Becker K; Häberle B; VON Schweinitz D; Kappler R; Berger M
Oncol Lett; 2016 Jan; 11(1):870-878. PubMed ID: 26870298
[TBL] [Abstract][Full Text] [Related]
2. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
3. Expression of Truncated Neurokinin-1 Receptor in Childhood Neuroblastoma is Independent of Tumor Biology and Stage.
Pohl A; Kappler R; Mühling J; VON Schweinitz D; Berger M
Anticancer Res; 2017 Nov; 37(11):6079-6085. PubMed ID: 29061788
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
[TBL] [Abstract][Full Text] [Related]
5. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer.
Beirith I; Renz BW; Mudusetti S; Ring NS; Kolorz J; Koch D; Bazhin AV; Berger M; Wang J; Angele MK; D'Haese JG; Guba MO; Niess H; Andrassy J; Werner J; Ilmer M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070805
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
[TBL] [Abstract][Full Text] [Related]
8. Induction of the neurokinin 1 receptor by TNFα in endometriotic tissue provides the potential for neurogenic control over endometriotic lesion growth.
McKinnon BD; Evers J; Bersinger NA; Mueller MD
J Clin Endocrinol Metab; 2013 Jun; 98(6):2469-77. PubMed ID: 23553861
[TBL] [Abstract][Full Text] [Related]
9. Neurokinin-1 Receptor Antagonists against Hepatoblastoma.
Muñoz M; Rosso M; Coveñas R
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466222
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Innovations for Targeting Hepatoblastoma.
Garnier A; Ilmer M; Kappler R; Berger M
Anticancer Res; 2016 Nov; 36(11):5577-5592. PubMed ID: 27793881
[TBL] [Abstract][Full Text] [Related]
11. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract][Full Text] [Related]
12. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
[TBL] [Abstract][Full Text] [Related]
13. Targeting tachykinin receptors in neuroblastoma.
Henssen AG; Odersky A; Szymansky A; Seiler M; Althoff K; Beckers A; Speleman F; Schäfers S; De Preter K; Astrahanseff K; Struck J; Schramm A; Eggert A; Bergmann A; Schulte JH
Oncotarget; 2017 Jan; 8(1):430-443. PubMed ID: 27888795
[TBL] [Abstract][Full Text] [Related]
14. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
[TBL] [Abstract][Full Text] [Related]
15. Role of Pituitary Adenylate-Cyclase Activating Polypeptide and Tac1 gene derived tachykinins in sensory, motor and vascular functions under normal and neuropathic conditions.
Botz B; Imreh A; Sándor K; Elekes K; Szolcsányi J; Reglődi D; Quinn JP; Stewart J; Zimmer A; Hashimoto H; Helyes Z
Peptides; 2013 May; 43():105-12. PubMed ID: 23499760
[TBL] [Abstract][Full Text] [Related]
16. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts.
Muñoz M; Berger M; Rosso M; Gonzalez-Ortega A; Carranza A; Coveñas R
Int J Oncol; 2014 Jan; 44(1):137-46. PubMed ID: 24190675
[TBL] [Abstract][Full Text] [Related]
18. The Neurokinin-1 Receptor Contributes to the Early Phase of Lipopolysaccharide-Induced Fever
Pakai E; Tekus V; Zsiboras C; Rumbus Z; Olah E; Keringer P; Khidhir N; Matics R; Deres L; Ordog K; Szentes N; Pohoczky K; Kemeny A; Hegyi P; Pinter E; Garami A
Front Immunol; 2018; 9():166. PubMed ID: 29459872
[TBL] [Abstract][Full Text] [Related]
19. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
20. Generation of a NK1R-CreER knockin mouse strain to study cells involved in Neurokinin 1 Receptor signaling.
Huang H; Kuzirian MS; Cai X; Snyder LM; Cohen J; Kaplan DH; Ross SE
Genesis; 2016 Nov; 54(11):593-601. PubMed ID: 27712014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
